KathleenJBeachMDMPH

PubMed

• 14 citations
  Development of standard definitions and grading for Maternal and Fetal Adverse Event Terminology.
  Rebecca Spencer, Kurt Hecher, Gill Norman, Karel Marsal, Jan Deprest, Alan W. Flake, Francesc Figueras, Christoph Lees, Steve Thornton, Kathleen J. Beach, Marcy Powell...> ;Prenatal Diagnosis. 2021 Oct 12
• Safety and Outcomes in Infants Born to Mothers Participating in Retosiban Treatment Trials: ARIOS Follow-Up Study.
  Marcy Powell, George R. Saade, Steve Thornton, Jeanne M. Pimenta, Nazneen Haque, Diane Miller, Kathleen J. Beach, Jerry Snidow, Erika del Carmen Ochoa Correa, Rhona Scott> ;American Journal of Perinatology. 2021 Aug 5
• 1 citations
  Erratum: Randomized Trials of Retosiban versus Placebo or Atosiban in Spontaneous Preterm Labor.
  George Saade, Andrew Shennan, Kathleen J Beach, Eran Hadar, Barbara V Parilla, Jerry Snidow, Marcy Powell, Timothy H Montague, Feng Liu, Yosuke Komatsu, Laura McKain, ...> ;American Journal of Perinatology. 2021 Aug 1
• 4 citations
  Randomized Trials of Retosiban Versus Placebo or Atosiban in Spontaneous Preterm Labor.
  George R Saade, Andrew Shennan, Kathleen J Beach, Eran Hadar, Barbara V Parilla, Jerry Snidow, Marcy Powell, Timothy H Montague, Feng Liu, Yosuke Komatsu, Laura McKain...> ;American Journal of Perinatology. 2021 Aug 1
• 1 citations
  Assessing a composite end point for new tocolytics in clinical trials: Data from 4 US integrated delivery networks.
  Jeanne M. Pimenta, Emma Brinkley, Timothy H. Montague, Kathleen J. Beach, Christina D. Mack> ;Pharmacoepidemiology and Drug Safety. 2018 Feb 1
• 6 citations
  A Retrospective Database Analysis of Neonatal Morbidities to Evaluate a Composite Endpoint for Use in Preterm Labor Clinical Trials.
  Jeanne M. Pimenta, Myla Ebeling, Timothy H. Montague, Kathleen J. Beach, Jill Abell, Michael O'Shea, Marcy Powell, Thomas C. Hulsey> ;AJP Reports. 2018 Jan 1
• A Phase 1 Randomized, Placebo-Controlled Study Assessing the Pharmacokinetics, Safety, and Tolerability of Retosiban in Healthy, Nonpregnant Japanese Subjects.
  Stephen Caltabiano, Mindy Magee, Feng Liu, Kathleen J. Beach> ;Clinical Pharmacology in Drug Development. 2018 Jan 1
• 16 citations
  Treatment of spontaneous preterm labour with retosiban: a phase 2 proof-of-concept study
  Steven Thornton, Hugh Miller, Guillermo J. Valenzuela, Jerry Snidow, Brendt Stier, Michael J. Fossler, Timothy H. Montague, Marcy Powell, Kathleen J. Beach> ;British Journal of Clinical Pharmacology. 2015 Oct 1
• 14 citations
  Effects of aggregation of drug and diagnostic codes on the performance of the high-dimensional propensity score algorithm: an empirical example
  Charles Poole, M. Alan Brookhart, Victor J. Schoenbach, Kathleen J. Beach, J. Bradley Layton, Til Stürmer> ;BMC Medical Research Methodology. 2013 Nov 19
• 23 citations
  Characterizing phenotypes and outcomes of drug‐associated liver injury using electronic medical record data
  Janet Shin, Christine M. Hunt, Ayako Suzuki, Julie I. Papay, Kathleen J. Beach, T. Craig Cheetham> ;Pharmacoepidemiology and Drug Safety. 2013 Feb 1
• 4 citations
  Performance of a semi-automated approach for risk estimation using a common data model for longitudinal healthcare databases.
  Kathleen J Beach, Gregory Powell, Ed Pattishall, Patrick B. Ryan, Robertino M Mera> ;Statistical Methods in Medical Research. 2013 Feb 1
• 167 citations
  Thromboembolic events among adult patients with primary immune thrombocytopenia in the United Kingdom General Practice Research Database
  Ameet Sarpatwari, Dimitri Bennett, John Logie, Amit Shukla, Kathleen J. Beach, Adrian C. Newland, Simon Sanderson, Drew Provan> ;Haematologica. 2010 Jul 1
• 6 citations
  Semi-automated risk estimation using large databases: quinolones and clostridium difficile associated diarrhea†
  Robertino M. Mera, Kathleen J. Beach, Gregory E. Powell, Edward N. Pattishall> ;Pharmacoepidemiology and Drug Safety. 2010 Jun 1
• 5 citations
  Incidence of autism over time.
  Hershel Jick, Kathleen J. Beach, James A. Kaye> ;Epidemiology. 2006 Jan 1
• 121 citations
  Unexpected association between induction of immunity to the universal tumor antigen CYP1B1 and response to next therapy.
  John G. Gribben, David P. Ryan, Richard Boyajian, Robert G. Urban, Mary Lynne Hedley, Kathleen Beach, Patrick Nealon, Ursula A. Matulonis, Susana M. Campos, Timothy D....> ;Clinical Cancer Research. 2005 Jun 15
• 25 citations
  Dynamics of Human Papillomavirus Infection between Biopsy and Excision of Cervical Intraepithelial Neoplasia: Results from the ZYC101a Protocol
  Christopher P. Crum, Kathleen Beach, Mary Lynne Hedley, Liping Yuan, Kenneth R. Lee, Thomas C. Wright, Robert G. Urban> ;The Journal of Infectious Diseases. 2004 Apr 15
• 134 citations
  ZYC101a for Treatment of High-Grade Cervical Intraepithelial Neoplasia: A Randomized Controlled Trial
  Francisco A.R. Garcia, Karl Ulrich Petry, Laila I. Muderspach, Michael A. Gold, Patricia S. Braly, Christopher P. Crum, Marianne Magill, Michael H. Silverman, Robert G...> ;Obstetrics and Gynecology. 2004 Feb 1
• 33 citations
  Production of pathogen-inactivated RBC concentrates using PEN110 chemistry: a Phase I clinical study.
  James P. AuBuchon, Constance Pickard, Louise Herschel, Jill Roger, James E. Tracy, Andrei Purmal, John Chapman, Samuel K. Ackerman, Kathleen J. Beach> ;Transfusion. 2002 Feb 1
• Call for post-licensing human pharmacokinetic studies of administration of recombinant factor IX.
  Courter SG, Beach KJ> ;Haemophilia. 1998 Mar
• 220 citations
  A randomized placebo-controlled trial of recombinant human interleukin-11 in cancer patients with severe thrombocytopenia due to chemotherapy
  Isidore Tepler, Laurence Elias, Mohamad A. Hussein, Gerald Rosen, Alex Y. C. Chang, Joseph O. Moore, Michael S. Gordon, Bernice Kuca, Kathleen J. Beach, John Loewy, Ma...> ;Blood. 1996 May 1
• 13 citations
  Communication barriers between attending physicians and residents
  Jack D. McCue, Kathleen J. Beach> ;Journal of General Internal Medicine. 1994 Mar 1
• Comorbidities of idiopathic thrombocytopenic purpura: a population-based study.
  Feudjo-Tepie, M. A., Le Roux, G., Beach, K. J., Bennett, D., Robinson, N. J.> ;Adv Hematol. 2009 Dec 05
• Randomized placebo-controlled study of recombinant human interleukin-11 to prevent chemotherapy-induced thrombocytopenia in patients with breast cancer receiving dose-...
  Isaacs, C., Robert, N. J., Bailey, F. A., Schuster, M. W., Overmoyer, B., Graham, M., Cai, B., Beach, K. J., Loewy, J. W., Kaye, J. A.> ;J Clin Oncol. 1997 Nov
• A phase I trial of recombinant human interleukin-11 (neumega rhIL-11 growth factor) in women with breast cancer receiving chemotherapy.
  Gordon, M. S., McCaskill-Stevens, W. J., Battiato, L. A., Loewy, J., Loesch, D., Breeden, E., Hoffman, R., Beach, K. J., Kuca, B., Kaye, J., Sledge, G. W.> ;Blood. 1996 May 1
• Join now to see all